MA30903B1 - Derives de 2 - phenyl-6-minocarbonyl-pyrimidine - Google Patents
Derives de 2 - phenyl-6-minocarbonyl-pyrimidineInfo
- Publication number
- MA30903B1 MA30903B1 MA31890A MA31890A MA30903B1 MA 30903 B1 MA30903 B1 MA 30903B1 MA 31890 A MA31890 A MA 31890A MA 31890 A MA31890 A MA 31890A MA 30903 B1 MA30903 B1 MA 30903B1
- Authority
- MA
- Morocco
- Prior art keywords
- phenyl
- pyrimidine derivatives
- minocarbonyl
- treatment
- viscerol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRÉSENTE INVENTION CONCERNE DES DÉRIVÉS DE 2-PHÉNYL-6-AMINOCARBONYL-PYRIMIDINE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DE RÉCEPTEUR P2Y12 DANS LE TRAITEMENT ET/OU LA PRÉVENTION ET/OU LE TRAITEMENT DE MALADIES ET ÉTATS VASCULAIRES PÉRIPHÉRIQUES, VISCÉRO-, HÉPATO- ET RÉNOVASCULAIRES, CARDIOVASCULAIRES ET CÉRÉBROVASCULAIRES ASSOCIÉS À L'AGRÉGATION PLAQUETTAIRE, TELS QUE LA THROMBOSE CHEZ LES ÊTRES HUMAINS ET AUTRES MAMMIFÈRES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2006053929 | 2006-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30903B1 true MA30903B1 (fr) | 2009-11-02 |
Family
ID=39324985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31890A MA30903B1 (fr) | 2006-10-25 | 2009-05-15 | Derives de 2 - phenyl-6-minocarbonyl-pyrimidine |
Country Status (22)
Country | Link |
---|---|
US (1) | US8044055B2 (fr) |
EP (1) | EP2079711B1 (fr) |
JP (1) | JP5144670B2 (fr) |
KR (1) | KR101434697B1 (fr) |
CN (1) | CN101528715B (fr) |
AR (1) | AR063518A1 (fr) |
AT (1) | ATE454377T1 (fr) |
AU (1) | AU2007310435A1 (fr) |
BR (1) | BRPI0717369A2 (fr) |
CA (1) | CA2664347C (fr) |
CL (1) | CL2007003038A1 (fr) |
DE (1) | DE602007004245D1 (fr) |
ES (1) | ES2339408T3 (fr) |
IL (1) | IL198334A0 (fr) |
MA (1) | MA30903B1 (fr) |
MX (1) | MX2009004186A (fr) |
NO (1) | NO20091985L (fr) |
PL (1) | PL2079711T3 (fr) |
RU (1) | RU2009119421A (fr) |
TW (1) | TW200829247A (fr) |
WO (1) | WO2008050301A2 (fr) |
ZA (1) | ZA200903574B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200640877A (en) | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
DK2225253T3 (da) | 2007-11-29 | 2012-08-27 | Actelion Pharmaceuticals Ltd | Phosphonsyrederivater og deres anvendelse som p2y12- receptorantagonister |
AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
CA2756542C (fr) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-azabicyclo[3.1.0]hex-3-yl)-2-phenylpyrimidines |
CN102405220B (zh) | 2009-04-22 | 2015-05-27 | 埃科特莱茵药品有限公司 | 噻唑衍生物及其作为p2y12受体拮抗剂的用途 |
WO2013033178A1 (fr) | 2011-08-30 | 2013-03-07 | University Of Utah Research Foundation | Procédés et compositions pour traiter le diabète insipide néphrogénique |
CN102992968B (zh) * | 2012-08-15 | 2014-07-16 | 河北工业大学 | 2,3-二甲氧基-1-丙醇及其制备方法 |
UA124073C2 (uk) | 2016-09-22 | 2021-07-14 | Ідорсія Фармасьютікалз Лтд | Кристалічні форми гідрохлориду складного бутилового ефіру 4-((r)-2-{[6-((s)-3-метоксипіролідин-1-іл)-2-фенілпіримідин-4-карбоніл]-аміно}-3-фосфонопропіоніл)-піперазин-1-карбонової кислоти |
EP3595666A1 (fr) | 2017-03-15 | 2020-01-22 | Idorsia Pharmaceuticals Ltd | Administration sous-cutanée d'un antagoniste du récepteur p2y12 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5373586A (en) * | 1976-12-09 | 1978-06-30 | Mitsubishi Chem Ind Ltd | New penicillin derivatives |
JPS61227572A (ja) * | 1985-04-02 | 1986-10-09 | Ishihara Sangyo Kaisha Ltd | N−ベンゾイル−n′−ピリミジニルオキシフエニルウレア系化合物及びそれらを含有する抗癌剤 |
EP1192132B1 (fr) * | 1999-06-14 | 2005-09-07 | Eli Lilly And Company | Composes |
US6861424B2 (en) * | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
CN1181062C (zh) * | 2001-12-28 | 2004-12-22 | 陈依军 | 2-苯氧基嘧啶衍生物及其治疗用途 |
JP4662777B2 (ja) * | 2002-12-11 | 2011-03-30 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 血小板アデノシン二リン酸受容体アンタゴニストとしての2−アミノカルボニルキノリン化合物 |
TW200640877A (en) * | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
DK2225253T3 (da) | 2007-11-29 | 2012-08-27 | Actelion Pharmaceuticals Ltd | Phosphonsyrederivater og deres anvendelse som p2y12- receptorantagonister |
AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
CA2756542C (fr) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-azabicyclo[3.1.0]hex-3-yl)-2-phenylpyrimidines |
CN102405220B (zh) | 2009-04-22 | 2015-05-27 | 埃科特莱茵药品有限公司 | 噻唑衍生物及其作为p2y12受体拮抗剂的用途 |
-
2007
- 2007-10-23 AR ARP070104678A patent/AR063518A1/es unknown
- 2007-10-23 CL CL200703038A patent/CL2007003038A1/es unknown
- 2007-10-24 JP JP2009534029A patent/JP5144670B2/ja active Active
- 2007-10-24 KR KR1020097009600A patent/KR101434697B1/ko active IP Right Grant
- 2007-10-24 DE DE602007004245T patent/DE602007004245D1/de active Active
- 2007-10-24 MX MX2009004186A patent/MX2009004186A/es active IP Right Grant
- 2007-10-24 PL PL07826850T patent/PL2079711T3/pl unknown
- 2007-10-24 RU RU2009119421/04A patent/RU2009119421A/ru not_active Application Discontinuation
- 2007-10-24 CA CA2664347A patent/CA2664347C/fr active Active
- 2007-10-24 TW TW096139907A patent/TW200829247A/zh unknown
- 2007-10-24 AT AT07826850T patent/ATE454377T1/de active
- 2007-10-24 EP EP07826850A patent/EP2079711B1/fr active Active
- 2007-10-24 US US12/447,039 patent/US8044055B2/en active Active
- 2007-10-24 ES ES07826850T patent/ES2339408T3/es active Active
- 2007-10-24 BR BRPI0717369-5A2A patent/BRPI0717369A2/pt not_active IP Right Cessation
- 2007-10-24 CN CN2007800399452A patent/CN101528715B/zh active Active
- 2007-10-24 WO PCT/IB2007/054325 patent/WO2008050301A2/fr active Application Filing
- 2007-10-24 AU AU2007310435A patent/AU2007310435A1/en not_active Abandoned
-
2009
- 2009-04-23 IL IL198334A patent/IL198334A0/en unknown
- 2009-05-15 MA MA31890A patent/MA30903B1/fr unknown
- 2009-05-22 ZA ZA200903574A patent/ZA200903574B/xx unknown
- 2009-05-22 NO NO20091985A patent/NO20091985L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2079711A2 (fr) | 2009-07-22 |
BRPI0717369A2 (pt) | 2014-10-07 |
TW200829247A (en) | 2008-07-16 |
JP5144670B2 (ja) | 2013-02-13 |
DE602007004245D1 (de) | 2010-02-25 |
US20090291962A1 (en) | 2009-11-26 |
MX2009004186A (es) | 2009-05-11 |
US8044055B2 (en) | 2011-10-25 |
ZA200903574B (en) | 2010-08-25 |
ES2339408T3 (es) | 2010-05-19 |
ATE454377T1 (de) | 2010-01-15 |
AR063518A1 (es) | 2009-01-28 |
NO20091985L (no) | 2009-05-22 |
CN101528715A (zh) | 2009-09-09 |
PL2079711T3 (pl) | 2010-06-30 |
RU2009119421A (ru) | 2011-04-27 |
CA2664347C (fr) | 2014-10-21 |
CA2664347A1 (fr) | 2008-05-02 |
KR101434697B1 (ko) | 2014-08-27 |
IL198334A0 (en) | 2010-02-17 |
CN101528715B (zh) | 2011-08-24 |
WO2008050301A2 (fr) | 2008-05-02 |
CL2007003038A1 (es) | 2008-06-06 |
KR20090068278A (ko) | 2009-06-25 |
JP2010507646A (ja) | 2010-03-11 |
AU2007310435A1 (en) | 2008-05-02 |
EP2079711B1 (fr) | 2010-01-06 |
WO2008050301A3 (fr) | 2008-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30903B1 (fr) | Derives de 2 - phenyl-6-minocarbonyl-pyrimidine | |
MA30868B1 (fr) | Derives de 2-aminocarbonyl-pyridine | |
MA32277B1 (fr) | Derives de 2-phenyl-4- cyclopropyl-pyrimidine | |
MA33277B1 (fr) | Dérivés de thiazole et leur utilisation comme antagonistes des récepteurs p2y12 | |
MA31767B1 (fr) | Composes organiques et leurs utilisations | |
WO2006114774A3 (fr) | Derives de pyrimidine | |
MA31983B1 (fr) | Dérivés d'acide phosphonique et leur utilisation en tant qu'antagonistes du récepteur p2y12 | |
MA33260B1 (fr) | 6-(3-azabicyclo[3.1.0.]hex-3-yl)-2-phenylpyrimidines | |
MA30900B1 (fr) | Anticorps d'agonistes anti-notch3 et leur utilisation dans le traitement de maladies liées à notch3 | |
MA43094A1 (fr) | Dérivés de maytansinoïde, leurs conjugués, et procédés d'utilisation | |
MA32226B1 (fr) | Compositions et leurs procedes de preparation et d'utilisation | |
MA30906B1 (fr) | Composes et compositions en tant quinhibiteurs des proteines kinases | |
MA32282B1 (fr) | Dérivés de 2-phényl-pyridine substitués | |
MA42376B1 (fr) | Dérivés d'oxopyridine substitués | |
EA200801343A1 (ru) | Иммуноглобулины, направленные против nogo | |
MA34721B1 (fr) | Acides carboxyliques 1-benzylcycloalkyle substitués et leur utilisation | |
MA31920B1 (fr) | 4-(4-cyano-2-thioaryle)-dihydropyrimidinone et son utilisation | |
MA30384B1 (fr) | Therapies combinatoires | |
MA31245B1 (fr) | Amides de 4-aryl-1,4-dihydro-1,6-naphthyridine substitués et utilisation de ceux-ci | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
MA31570B1 (fr) | Oxazolidinones substitués et leur utilisation | |
BRPI0513317A (pt) | ciclosporinas para tratar doença de alzheimer | |
MA30485B1 (fr) | Aminothiazoles et leurs utilisations | |
MA43113B1 (fr) | Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci | |
MA31535B1 (fr) | (oxazolidinon-5-yl-méthyl)-2-thiophène-carboxamides substitués et leur utilisation dans le domaine de la coagulation sanguine |